Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001477932-25-001339
Filing Date
2025-02-28
Accepted
2025-02-27 21:06:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFR 14A bglc_defr14a.htm DEFR14A 207708
  Complete submission text file 0001477932-25-001339.txt   208937
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-41750 | Film No.: 25682197
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)